FL-2000 study for newly diagnosed follicular lymphoma patients with a high tumor burden

Trial Profile

FL-2000 study for newly diagnosed follicular lymphoma patients with a high tumor burden

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2008

At a glance

  • Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Interferon alpha-2a; Prednisolone
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Dec 2008 Primary endpoint 'Event free survival rate' has been met.
    • 02 Jul 2007 Status changed from in progress to completed
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top